Investigational Site Number :7240004

Majadahonda, Madrid 28222

1 studies enrolling now · 2 studies all time

What they study most

Non-relapsing Secondary Progressive Multiple Sclerosis, Polyneuropathy, Inflammatory Demyelinating, Chronic

Studies at this site

• Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP — Enrolling by invitation
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed